Jun 9, 2026 07:45AM
Jun 9, 2026 07:45AM
Jun 1, 2026 08:15AM
Jun 1, 2026 08:15AM
Mar 13, 2026 08:15AM
Mar 13, 2026 08:15AM
Nov 18, 2025 08:00AM Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
Oct 27, 2025 08:30AM
Oct 20, 2025 04:24PM
Oct 20, 2025 04:19PM
Sep 11, 2025 09:18AM
Sep 9, 2025 09:28AM
Sep 9, 2025 09:28AM
Aug 25, 2025 09:15AM Aditxt subsidiary Adimune plans FDA trials for autoimmune treatments
Aug 25, 2025 09:15AM
Aug 21, 2025 08:56AM
Aug 19, 2025 09:39AM
Aug 14, 2025 08:46AM
Aug 11, 2025 08:30AM
Aug 11, 2025 08:30AM
Aug 5, 2025 08:46AM Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference
Jul 29, 2025 09:05AM
Jul 29, 2025 09:00AM
Jul 24, 2025 08:15AM
Jul 24, 2025 08:15AM
Jul 15, 2025 09:12AM
Jul 7, 2025 08:16AM
Jul 7, 2025 08:15AM Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization
Jun 11, 2025 08:14AM
Jun 9, 2025 08:15AM
Jun 9, 2025 08:15AM
Jun 5, 2025 08:15AM
May 19, 2025 08:00AM
May 2, 2025 09:00AM
Apr 17, 2025 08:15AM Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary
Apr 16, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 11, 2025 08:15AM
Apr 11, 2025 08:15AM
Apr 2, 2025 08:15AM
Mar 28, 2025 08:15AM Upcoming Aditxt Weekly Update to Highlight Pearsanta’s Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection
Mar 24, 2025 08:30AM
Mar 24, 2025 08:15AM
Mar 18, 2025 07:37AM
Mar 18, 2025 07:22AM
Mar 17, 2025 08:15AM
Mar 17, 2025 08:15AM
Mar 12, 2025 04:15PM Aditxt, Inc (ADTX) Announces 1:250 Reverse Share Split
Mar 12, 2025 04:15PM

1,157,986 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All